-
1
-
-
33846857559
-
Heart disease and stroke statistics- 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171.
-
(2007)
Circulation
, vol.115
-
-
Rosamond, W.1
Flegal, K.2
Friday, G.3
Furie, K.4
Go, A.5
Greenlund, K.6
Haase, N.7
Ho, M.8
Howard, V.9
Kissela, B.10
Kittner, S.11
Lloyd-Jones, D.12
McDermott, M.13
Meigs, J.14
Moy, C.15
Nichol, G.16
O'Donnell, C.J.17
Roger, V.18
Rumsfeld, J.19
Sorlie, P.20
Steinberger, J.21
Thom, T.22
Wasserthiel-Smoller, S.23
Hong, Y.24
more..
-
2
-
-
17844403494
-
Prevalence of anemia and effects on mortality in patients with heart failure.
-
Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 2005;149:391-401.
-
(2005)
Am Heart J
, vol.149
, pp. 391-401
-
-
Lindenfeld, J.1
-
3
-
-
49849088979
-
Anemia and mortality in heart failure patients a systematic review and meta-analysis.
-
Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-827.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 818-827
-
-
Groenveld, H.F.1
Januzzi, J.L.2
Damman, K.3
Van Wijngaarden, J.4
Hillege, H.L.5
Van Veldhuisen, D.J.6
Van Der Meer, P.7
-
4
-
-
0037024202
-
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.
-
Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 1780-1786
-
-
Horwich, T.B.1
Fonarow, G.C.2
Hamilton, M.A.3
MacLellan, W.R.4
Borenstein, J.5
-
5
-
-
0037378082
-
Effect of anemia on exercise tolerance in chronic heart failure in men.
-
Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP, Poole-Wilson PA, Coats AJ, Anker SD. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003;91:888-891.
-
(2003)
Am J Cardiol
, vol.91
, pp. 888-891
-
-
Kalra, P.R.1
Bolger, A.P.2
Francis, D.P.3
Genth-Zotz, S.4
Sharma, R.5
Ponikowski, P.P.6
Poole-Wilson, P.A.7
Coats, A.J.8
Anker, S.D.9
-
6
-
-
37549048168
-
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).
-
Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, She L, Sun JL, Yancy CW, Fonarow GC. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 2008;101: 223-230.
-
(2008)
Am J Cardiol
, vol.101
, pp. 223-230
-
-
Young, J.B.1
Abraham, W.T.2
Albert, N.M.3
Gattis Stough, W.4
Gheorghiade, M.5
Greenberg, B.H.6
O'Connor, C.M.7
She, L.8
Sun, J.L.9
Yancy, C.W.10
Fonarow, G.C.11
-
7
-
-
18144392003
-
Correlates of cognitive impairment among patients with heart failure: Results of a multicenter survey.
-
Zuccala G, Marzetti E, Cesari M, Lo Monaco MR, Antonica L, Cocchi A, Carbonin P, Bernabei R. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med 2005;118:496-502.
-
(2005)
Am J Med
, vol.118
, pp. 496-502
-
-
Zuccala, G.1
Marzetti, E.2
Cesari, M.3
Lo Monaco, M.R.4
Antonica, L.5
Cocchi, A.6
Carbonin, P.7
Bernabei, R.8
-
8
-
-
0034812030
-
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.
-
Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-962.
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 955-962
-
-
Al-Ahmad, A.1
Rand, W.M.2
Manjunath, G.3
Konstam, M.A.4
Salem, D.N.5
Levey, A.S.6
Sarnak, M.J.7
-
9
-
-
24044458237
-
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: Results from Val-HeFT.
-
Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, Chiang YT, Aknay N, Maggioni AP, Opasich C, Latini R, Cohn JN. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 2005;112:1121-1127.
-
(2005)
Circulation
, vol.112
, pp. 1121-1127
-
-
Anand, I.S.1
Kuskowski, M.A.2
Rector, T.S.3
Florea, V.G.4
Glazer, R.D.5
Hester, A.6
Chiang, Y.T.7
Aknay, N.8
Maggioni, A.P.9
Opasich, C.10
Latini, R.11
Cohn, J.N.12
-
10
-
-
0043011312
-
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.
-
Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003;92:625-628.
-
(2003)
Am J Cardiol
, vol.92
, pp. 625-628
-
-
Felker, G.M.1
Gattis, W.A.2
Leimberger, J.D.3
Adams, K.F.4
Cuffe, M.S.5
Gheorghiade, M.6
O'Connor, C.M.7
-
11
-
-
33745697922
-
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: Results from COMET.
-
Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 2006;27:1440-1446.
-
(2006)
Eur Heart J
, vol.27
, pp. 1440-1446
-
-
Komajda, M.1
Anker, S.D.2
Charlesworth, A.3
Okonko, D.4
Metra, M.5
Di Lenarda, A.6
Remme, W.7
Moullet, C.8
Swedberg, K.9
Cleland, J.G.10
Poole-Wilson, P.A.11
-
12
-
-
0036296978
-
Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study.
-
McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-1936.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1928-1936
-
-
McClellan, W.M.1
Flanders, W.D.2
Langston, R.D.3
Jurkovitz, C.4
Presley, R.5
-
13
-
-
0037458127
-
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.
-
Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003;107:294-299.
-
(2003)
Circulation
, vol.107
, pp. 294-299
-
-
Mancini, D.M.1
Katz, S.D.2
Lang, C.C.3
Lamanca, J.4
Hudaihed, A.5
Androne, A.S.6
-
14
-
-
33845216454
-
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
-
Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabro A, Campagna SM, Nuti R. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 2006;152: 1096. e1099-1015.
-
(2006)
Am Heart J
, vol.152-1096
-
-
Palazzuoli, A.1
Silverberg, D.2
Iovine, F.3
Capobianco, S.4
Giannotti, G.5
Calabro, A.6
Campagna, S.M.7
Nuti, R.8
-
15
-
-
0035370037
-
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study.
-
Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S, Shapira I, Laniado S, Iaina A. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775-1780.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 1775-1780
-
-
Silverberg, D.S.1
Wexler, D.2
Sheps, D.3
Blum, M.4
Keren, G.5
Baruch, R.6
Schwartz, D.7
Yachnin, T.8
Steinbruch, S.9
Shapira, I.10
Laniado, S.11
Iaina, A.12
-
16
-
-
41049115024
-
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
-
Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 2008;117:526-535.
-
(2008)
Circulation
, vol.117
, pp. 526-535
-
-
Ghali, J.K.1
Anand, I.S.2
Abraham, W.T.3
Fonarow, G.C.4
Greenberg, B.5
Krum, H.6
Massie, B.M.7
Wasserman, S.M.8
Trotman, M.L.9
Sun, Y.10
Knusel, B.11
Armstrong, P.12
-
17
-
-
33846936320
-
Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure. A Randomized, Double-Blind, Placebo-Controlled Trial
-
DOI 10.1016/j.jacc.2006.11.024, PII S0735109706029858
-
Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R, Ryan E, Wasserman SM, Baker N, Rosser D, Rosen SD, Poole-Wilson PA, Banasiak W, Coats AJ, McDonald K. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2007;49:753-762. (Pubitemid 46240705)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.7
, pp. 753-762
-
-
Ponikowski, P.1
Anker, S.D.2
Szachniewicz, J.3
Okonko, D.4
Ledwidge, M.5
Zymlinski, R.6
Ryan, E.7
Wasserman, S.M.8
Baker, N.9
Rosser, D.10
Rosen, S.D.11
Poole-Wilson, P.A.12
Banasiak, W.13
Coats, A.J.S.14
McDonald, K.15
-
18
-
-
34548798205
-
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
-
DOI 10.1093/eurheartj/ehm328
-
van Veldhuisen DJ, Dickstein K, Cohen-Solal A, Lok DJ, Wasserman SM, Baker N, Rosser D, Cleland JG, Ponikowski P. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J 2007;28:2208-2216. (Pubitemid 47428946)
-
(2007)
European Heart Journal
, vol.28
, Issue.18
, pp. 2208-2216
-
-
Van Veldhuisen, D.J.1
Dickstein, K.2
Cohen-Solal, A.3
Lok, D.J.A.4
Wasserman, S.M.5
Baker, N.6
Rosser, D.7
Cleland, J.G.F.8
Ponikowski, P.9
-
19
-
-
33646905411
-
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients.
-
Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 2006;98: 708-714.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 708-714
-
-
Bohlius, J.1
Wilson, J.2
Seidenfeld, J.3
Piper, M.4
Schwarzer, G.5
Sandercock, J.6
Trelle, S.7
Weingart, O.8
Bayliss, S.9
Djulbegovic, B.10
Bennett, C.L.11
Langensiepen, S.12
Hyde, C.13
Engert, A.14
-
20
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
-
Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-2084.
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
Eckardt, K.U.4
MacDougall, I.C.5
Tsakiris, D.6
Burger, H.U.7
Scherhag, A.8
-
21
-
-
33846669860
-
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with ery-thropoietin: A meta-analysis.
-
Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with ery-thropoietin: a meta-analysis. Lancet 2007;369:381-388.
-
(2007)
Lancet
, vol.369
, pp. 381-388
-
-
Phrommintikul, A.1
Haas, S.J.2
Elsik, M.3
Krum, H.4
-
22
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease.
-
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355: 2085-2098.
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
Barnhart, H.4
Sapp, S.5
Wolfson, M.6
Reddan, D.7
-
23
-
-
0025913812
-
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
-
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
-
24
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial.
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
25
-
-
0033549290
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353: 2001-2007.
-
(1999)
Lancet
, vol.353
, pp. 2001-2007
-
-
-
26
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker val-sartan in chronic heart failure.
-
Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker val-sartan in chronic heart failure. N Engl J Med 2001;345:1667-1675.
-
(2001)
N Engl J Med
, vol.345
, pp. 1667-1675
-
-
Cohn, J.N.1
Tognoni, G.2
-
27
-
-
0033517302
-
Randomized Aldactone Evaluation Study Investigators. the effect of spironolac-tone on morbidity and mortality in patients with severe heart failure.
-
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, Randomized Aldactone Evaluation Study Investigators. The effect of spironolac-tone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
28
-
-
0042410539
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-overall programme
-
DOI 10.1016/S0140-6736(03)14282-1
-
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759-766. (Pubitemid 37093915)
-
(2003)
Lancet
, vol.362
, Issue.9386
, pp. 759-766
-
-
Pfeffer, M.A.1
Swedberg, K.2
Granger, C.B.3
Held, P.4
McMurray, J.J.V.5
Michelson, E.L.6
Olofsson, B.7
Ostergren, J.8
Yusuf, S.9
-
29
-
-
31644432097
-
Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment.
-
McMurray JJ. Chronic kidney disease in patients with cardiac disease: a review of evidence-based treatment. Kidney Int 2005;68:1419-1426.
-
(2005)
Kidney Int
, vol.68
, pp. 1419-1426
-
-
McMurray, J.J.1
-
30
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification.
-
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl. 2 1):S1-S266.
-
(2002)
Am J Kidney Dis
, vol.39
, Issue.SUPPL. 2 1
-
-
-
32
-
-
33646345152
-
KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease.
-
KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(Suppl. 5 3):S11-S145.
-
(2006)
Am J Kidney Dis
, vol.47
, Issue.SUPPL. 5 3
-
-
-
33
-
-
65449117261
-
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials.
-
Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009;373:1532-1542.
-
(2009)
Lancet
, vol.373
, pp. 1532-1542
-
-
Bohlius, J.1
Schmidlin, K.2
Brillant, C.3
Schwarzer, G.4
Trelle, S.5
Seidenfeld, J.6
Zwahlen, M.7
Clarke, M.8
Weingart, O.9
Kluge, S.10
Piper, M.11
Rades, D.12
Steensma, D.P.13
Djulbegovic, B.14
Fey, M.F.15
Ray-Coquard, I.16
MacHtay, M.17
Moebus, V.18
Thomas, G.19
Untch, M.20
Schumacher, M.21
Egger, M.22
Engert, A.23
more..
-
34
-
-
0041976976
-
Breast cancer trial with erythropoietin terminated unexpectedly
-
DOI 10.1016/S1470-2045(03)01163-X
-
Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003;4:459-460. (Pubitemid 37009952)
-
(2003)
Lancet Oncology
, vol.4
, Issue.8
, pp. 459-460
-
-
Leyland-Jones, B.1
-
35
-
-
24944454286
-
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study.
-
Leyland-Jones B, Semiglazov V, Pawlicki M, Pienkowski T, Tjulandin S, Manikhas G, Makhson A, Roth A, Dodwell D, Baselga J, Biakhov M, Valuckas K, Voznyi E, Liu X, Vercammen E. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005;23:5960-5972.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5960-5972
-
-
Leyland-Jones, B.1
Semiglazov, V.2
Pawlicki, M.3
Pienkowski, T.4
Tjulandin, S.5
Manikhas, G.6
Makhson, A.7
Roth, A.8
Dodwell, D.9
Baselga, J.10
Biakhov, M.11
Valuckas, K.12
Voznyi, E.13
Liu, X.14
Vercammen, E.15
-
36
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
-
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-590.
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
Egrie, J.C.4
Nissenson, A.R.5
Okamoto, D.M.6
Schwab, S.J.7
Goodkin, D.A.8
-
37
-
-
33846682340
-
Understanding recent haemoglobin trials in CKD: Methods and lesson learned from CREATE and CHOIR.
-
Levin A. Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 2007;22:309-312.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 309-312
-
-
Levin, A.1
-
38
-
-
37349022921
-
Exploring relative mortality and epoetin alfa dose among hemodia-lysis patients.
-
Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Exploring relative mortality and epoetin alfa dose among hemodia-lysis patients. Am J Kidney Dis 2008;51:62-70.
-
(2008)
Am J Kidney Dis
, vol.51
, pp. 62-70
-
-
Bradbury, B.D.1
Wang, O.2
Critchlow, C.W.3
Rothman, K.J.4
Heagerty, P.5
Keen, M.6
Acquavella, J.F.7
-
39
-
-
17844369963
-
Rationale-Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease.
-
Mix TC, Brenner RM, Cooper ME, de Zeeuw D, Ivanovich P, Levey AS, McGill JB, McMurray JJ, Parfrey PS, Parving HH, Pereira BJ, Remuzzi G, Singh AK, Solomon SD, Stehman-Breen C, Toto RD, Pfeffer MA. Rationale-Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J 2005;149:408-413.
-
(2005)
Am Heart J
, vol.149
, pp. 408-413
-
-
Mix, T.C.1
Brenner, R.M.2
Cooper, M.E.3
De Zeeuw, D.4
Ivanovich, P.5
Levey, A.S.6
McGill, J.B.7
McMurray, J.J.8
Parfrey, P.S.9
Parving, H.H.10
Pereira, B.J.11
Remuzzi, G.12
Singh, A.K.13
Solomon, S.D.14
Stehman-Breen, C.15
Toto, R.D.16
Pfeffer, M.A.17
-
40
-
-
71049154040
-
-
Amgen Inc. Aranespw (darbepoetin alfa). For injection. Last accessed on 17 September, 2009
-
Amgen Inc. Aranespw (darbepoetin alfa). For injection. http://www.aranesp.com/professional/crf/full-prescribing-info/pi.jsp. Last accessed on 17 September, 2009.
-
-
-
-
41
-
-
71049167851
-
-
Summary of Product Characteristics, Last accessed on 17 September, 2009
-
ARANESPw (darbepoetin alfa). Summary of Product Characteristics, 2008. http://www.amgen.co.uk/pdfs/Aranesp-PFS-SPC-Feb-08.pdf. Last accessed on 17 September, 2009.
-
(2008)
ARANESPw (Darbepoetin Alfa)
-
-
-
42
-
-
33847785149
-
Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.
-
Van Veldhuisen DJ, McMurray JJ. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 2007;9:110-112.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 110-112
-
-
Van Veldhuisen, D.J.1
McMurray, J.J.2
-
43
-
-
33846668160
-
TM Trial.
-
[Abstract]
-
Young JBDR, Maggioni AP, McMurray JJV, O'Connor C, Pfeffer MA, Solomon S, Tendera M, van Veldhuisen DJ, Wasserman SM, Swedberg K. Reduction of Events With Darbepoetin alfa in Heart Failure (RED-HF)TM Trial. J Card Fail 2006;6(Suppl. 1):S77. [Abstract].
-
(2006)
J Card Fail
, vol.6
, Issue.SUPPL. 1
-
-
Jbdr, Y.1
Maggioni, A.P.2
McMurray, J.J.V.3
O'Connor, C.4
Pfeffer, M.A.5
Solomon, S.6
Tendera, M.7
Van Veldhuisen, D.J.8
Wasserman, S.M.9
Swedberg, K.10
|